50 results on '"Canonica, G.W."'
Search Results
2. Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study
3. What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis
4. The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Validation and assessment
5. Cross-cultural adaptation and validation of the RhinAsthma Patient Perspective (RAPP) in Spanish
6. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology
7. Characterization of circadian COPD symptoms by phenotype: Methodology of the STORICO observational study
8. Debates in allergy medicine: Molecular allergy diagnosis with ISAC will replace screenings by skin prick test in the future
9. Quality of sleep in allergic children and their parents
10. SQ HDM SLIT-tablet (ALK) in treatment of asthma – Post hoc results from a randomised trial
11. Asthma exacerbation in children: Relationship among pollens, weather, and air pollution
12. From “blockbusters” to “biosimilars”: An opportunity for patients, medical specialists and health care providers
13. COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion
14. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air
15. Biologics and global burden of asthma: A worldwide portrait and a call for action
16. Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing
17. General strategy for the management of bronchial asthma in pregnancy
18. Revue systématique des études en vie réelle d’efficacité et de tolérance de mépolizumab dans le traitement de l’asthme sévère éosinophilique
19. Étude prospective internationale en vie réelle du mépolizumab chez les patients souffrant d’asthme sévère à un an: REALITI-A
20. Why a registry of Chronic Urticaria (CUR) is needed
21. Long-term cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergy
22. The natural history of respiratory allergy: A follow-up study of 99 patients up to 10 years
23. Contrôle de l’asthme chez les patients présentant un asthme sévère à éosinophiles traités par mépolizumab en vraie vie : l’étude prospective REALITI-A
24. PRS62 Applying Multiple Criteria Decision Analysis (MCDA) to Assess the VALUE of Budesonide-Formoterol Maintenance and Reliever Therapy in Asthma- an Empirical Case Study
25. PRS50 Defining Type 2 Asthma and Patients Eligible to Dupilumab in Italy: A Biomarker-Based Analysis
26. PRS45 Obstructive Airway Diseases: Real Clinical Practice from the Large Italian Administrative Database of Fondazione Ricerca E Salute (RES)
27. PRS24 The CROSS-Coverage Effect of Dupilumab in Treating Coexisting Type 2 Inflammatory Diseases on the Italian National Health Service Expenditure.
28. Étude TRIGGER : efficacité et tolérance d’une triple association à dose fixe CSI/LABA/LAMA versus CSI/LABA et CSI/LABA + LAMA chez des asthmatiques non contrôlés
29. Analyse combinée des études TRIMARAN et TRIGGER : réduction des exacerbations sévères sous triple association à dose fixe en particules extrafines DPB/FF/BG versus DPB/FF dans les asthmes non contrôlés
30. Wytyczne EAACI/GA2LEN/EDF/WAO dotyczące definicji, klasyfikacji, rozpoznawania i leczenia pokrzywki: weryfikacja z 2013 roku z poprawkami
31. PRS67 GENDER DIFFERENCES IN ASTHMA PERCEPTION AND IMPACT ON QUALITY OF LIFE: A POST-HOC ANALYSIS OF THE PROXIMA OBSERVATIONAL STUDY
32. PRS72 - A COST ESTIMATION OF MANAGEMENT OF ALLERGIC ASTHMA IN ITALY
33. A 4 years follow up in children with moderate/severe asthma after discontinuation of 1 year treatment with omalizumab
34. Low Levels of Cytokines and Growth Factors in Serum of Allergic and Non-Allergic Top Atletes
35. Allergen Component Resolved Diagnostics in Multi-Sensitized Patients with Respiratory Symptoms
36. Serum Ctla-4 And Il-10 In Hymenoptera Venom Immunotherapy: Equivalence Of Different Induction Regimens
37. A11/264 – Global Asthma Physician & Patient (GAPP) survey: barriers to treatment – North American pediatric findings
38. A 3-Year Randomized Controlled Study with Sublingual Immunotherapy in Mite-Induced Respiratory Allergy
39. Cost-Effectiveness of Sublingual Specific Immuno-Therapy Versus Current Symptomatic Treatments in Adults with Allergic Rhinitis and Asthma, in the Societal Perspective
40. 181. Neutrophil myeloperoxidase (MPO) and eosinophil cationic protein (ECP) serum levels during steroid and antibiotic treatment in CF patients
41. Cytokines and Airways: Recent Insights and Therapeutic Implications
42. Allergen Immunotherapy: Therapeutic Vaccines for Allergic Diseases
43. Fenoterol effects on the in vitro immune response
44. Inhibition of the colony-forming capacity of human T-lymphocytes exerted by theophylline
45. WITHDRAWN: Scaling up strategies of the Chronic Respiratory Disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3 – Area 5)
46. WHY THYROID IS MAJOR SITE OF THYROID AUTOANTIBODY SYNTHESIS IN AUTOIMMUNE THYROID DISEASE
47. Grass pollen and asthma
48. 437 ICAM-1 expression and regulation on 3 epithelial cells: Relevance for allergic inflammation
49. 200 Nasal immunotherapy (NIT) to parietaria: Follow-up of a double blind study
50. 191 Kinetics of radiolabelled allergen administered by sublingual and oral route
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.